Prasugrel and topotecan recommended in final NICE guidance
This article was originally published in Scrip
Executive Summary
The UK's National Institute for health and Clinical Excellence (NICE) has issued final guidance for the use of Lilly's antithrombotic Efient (prasugrel) in combination with aspirin to prevent blood clots in the arteries of patients with acute coronary syndromes.